Beijing Advanced Medical Technologies key facts
as of Oct 2026- Manufacturer of implantable cardiovascular medical devices intended for intravascular therapies.
- Beijing Advanced Medical Technologies is valued at approximately $217.7M as of Oct 2026 (last reported valuation).
- It has raised $29.0M; the latest was PE Growth/Expansion ($29.0M) in Apr 2026.
- Notable investors include Beijing Daxing Investment Group, China Medical System, Minsheng Securities Investment.
- Status: Privately Held (backing).
Beijing Advanced Medical Technologies's last reported valuation, Apr 2026. Nothing priced has surfaced since.
- ·Watch Beijing Advanced Medical Technologies: the Monday email on marks, rounds and moves
Beijing Advanced Medical Technologies funding rounds
No funding rounds for Beijing Advanced Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Beijing Advanced Medical Technologies
3Beijing Advanced Medical Technologies valuation
Beijing Advanced Medical Technologies's last reported valuation was $218 million in Apr 2026. No priced round, secondary trade or fund mark has surfaced since.
Beijing Advanced Medical Technologies investors
3 investors are on record for Beijing Advanced Medical Technologies, including Beijing Daxing Investment Group, China Medical System and Minsheng Securities Investment.
About Beijing Advanced Medical Technologies
Manufacturer of implantable cardiovascular medical devices intended for intravascular therapies. The company's offerings include fully absorbable coronary stents, peripheral vascular stents, 3D multi axis precision printed stent products, intravascular implantable devices, interventional medical components, enabling improved mechanical performance, scalable production and next generation biodegradable treatment options for cardiovascular care.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2011
- Employees
- 70
- Website
- ametcorp.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.